BWA Form 4: Director/VP Stefan Demmerle reports three sales totaling 20,000 shares
Rhea-AI Filing Summary
Insider sales by BorgWarner director/officer Stefan Demmerle totaling 20,000 shares were reported. The Form 4 shows three separate sell transactions on 08/12/2025 and 08/13/2025: 5,000 shares at a weighted average price of $40.0437 (actual prices ranged $40.04–$40.05), 10,000 shares at $38.95, and 5,000 shares at $40.50. After these transactions the report lists the beneficial ownership balance as 229,039.69 shares (reported following the 08/13/2025 sale). The filing was submitted via attorney-in-fact and includes an explanation that the first sale price is a weighted average and that detailed per-price quantities are available on request.
Positive
- Timely and compliant disclosure under Section 16 with explanatory note about weighted-average pricing
- No derivative transactions reported, indicating these were straightforward stock dispositions
Negative
- Insider sold 20,000 shares across 08/12/2025–08/13/2025, reducing beneficial ownership from prior levels
- Sales include a block at $38.95, below the other reported prices, which may warrant attention to price timing
Insights
TL;DR: Director/officer Stefan Demmerle executed routine open-market sales totaling 20,000 BWA shares, reducing his beneficial holdings.
The transactions are standard Section 16 reporting of open-market dispositions: three sales across two days aggregating 20,000 shares with prices between $38.95 and $40.50. The filer discloses the weighted-average treatment for one block and offers to provide exact breakdowns on request. There is no derivative activity reported. For investors, this is a disclosure of insider liquidity rather than an operational or accounting event; impact is informational unless part of a broader pattern.
TL;DR: Filing appears compliant and timely, noting an attorney-in-fact signature and explanatory disclosure for weighted pricing.
The Form 4 identifies the reporting person as both a director and an officer (Vice President) and shows the form was filed by one reporting person via an attorney-in-fact. The explanatory note clarifies pricing methodology for one sale, which supports transparency. There are no indications of transactions under a 10b5-1 plan in the form checkboxes. This is a routine governance disclosure with neutral governance implications.